KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Return on Sales: 2013-2025

Historic Return on Sales for Precigen (PGEN) over the last 13 years, with Sep 2025 value amounting to -39.13%.

  • Precigen's Return on Sales fell 391.00% to -39.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -39.13%, marking a year-over-year decrease of 391.00%. This contributed to the annual value of -32.16% for FY2024, which is 1676.00% down from last year.
  • Precigen's Return on Sales amounted to -39.13% in Q3 2025, which was down 36.40% from -28.69% recorded in Q2 2025.
  • In the past 5 years, Precigen's Return on Sales registered a high of 3.81% during Q3 2022, and its lowest value of -39.13% during Q3 2025.
  • Moreover, its 3-year median value for Return on Sales was -28.69% (2025), whereas its average is -22.30%.
  • In the last 5 years, Precigen's Return on Sales spiked by 360bps in 2022 and then plummeted by 3,219bps in 2024.
  • Quarterly analysis of 5 years shows Precigen's Return on Sales stood at 0.39% in 2021, then soared by 281bps to 3.19% in 2022, then tumbled by 1,860bps to -15.41% in 2023, then plummeted by 1,676bps to -32.16% in 2024, then slumped by 391bps to -39.13% in 2025.
  • Its Return on Sales was -39.13% in Q3 2025, compared to -28.69% in Q2 2025 and -37.29% in Q1 2025.